Lilly rides Mounjaro, Zepbound to better
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
Related articles
Mystery artist who erected signs comparing pothole
A defiant resident infuriated by the potholes in their road has taken revenge on the council by erec2024-05-21Zayn Malik sends fans crazy as he announces his first ever solo gig
Zayn Malik has sent fans into a frenzy as he announced his first ever solo gig on Instagram on Wedne2024-05-21China Highway collapse kills at least 48 in Guangdong
BEIJING (AP) — The death toll climbed to 48 on Thursday as search efforts continued in southeastern2024-05-21Red Sox place Masataka Yoshida on 10
BOSTON (AP) — The Boston Red Sox placed designated hitter Masataka Yoshida on the 10-day injured lis2024-05-21California congressman urges closer consultation with tribes on offshore wind
A congressman who represents California’s north coast has sent a letter to federal regulators asking2024-05-21PSG, Barca set to renew Champions League rivalry
FC Barcelona come face to face with their recent past, while Atletico Madrid need their home form to2024-05-21
atest comment